【新藥】《Zephyr AI》將在2023年ASCO年會中，發布第三代「EGFR」抑製劑

 【新藥】《Zephyr AI》將在2023年ASCO年會中，發布第三代「EGFR」抑製劑

▌文章出處

 Businesswire

▌原文標題

 Zephyr AI Demonstrates Predictive Value of Artificial Intelligence (AI) with RWD for Label Expansion with Approved 3rd Generation EGFR Inhibitor at the 2023 ASCO Annual Meeting

▌Twitter

 https://twitter.com/aimedadviser/status/1665482426246742016

▌文章序號

 3625

｜智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.